YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO.LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.35 CNY | -3.76% |
|
-1.95% | -18.81% |
| Sales 2024 * | 7.62B 1.05B | Sales 2025 * | 9.2B 1.27B | Capitalization | 24.36B 3.36B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.1B 152M | Net income 2025 * | 1.84B 254M | EV / Sales 2024 * | 2.71 x |
| Net cash position 2024 * | 3.72B 514M | Net cash position 2025 * | 4.57B 631M | EV / Sales 2025 * | 2.15 x |
| P/E ratio 2024 * |
16.1
x | P/E ratio 2025 * |
13
x | Employees | 3,053 |
| Yield 2024 * |
1.79% | Yield 2025 * |
2.17% | Free-Float | 27.75% |
More Fundamentals
* Assessed data
More news
More recommendations
| 1 day | -0.95% | ||
| 1 week | +1.88% | ||
| Current month | -4.10% | ||
| 1 month | -7.24% | ||
| 3 months | -10.13% | ||
| 6 months | -23.23% | ||
| Current year | -15.64% |
1 week
54.58
58.80
1 month
54.5862.05
Current year
51.5072.00
1 year
51.50117.75
3 years
51.50289.35
5 years
51.50289.35
10 years
51.50289.35
| Managers | Title | Age | Since |
|---|---|---|---|
Zhen Yu Guo
CEO | Chief Executive Officer | 61 | 14-05-31 |
Long Wang
DFI | Director of Finance/CFO | 42 | 16-11-30 |
Mei Zhang
BRD | Director/Board Member | 45 | 12-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kui Zhou
BRD | Director/Board Member | 56 | 13-09-30 |
Zhen Yu Guo
CEO | Chief Executive Officer | 61 | 14-05-31 |
Rong Hui Yao
BRD | Director/Board Member | 60 | 19-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.07% | 11 M€ | +0.55% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 55.35 | -3.76% | 8 286 093 |
| 24-04-25 | 57.51 | -0.95% | 2,296,200 |
| 24-04-24 | 58.06 | -0.53% | 2,535,829 |
| 24-04-23 | 58.37 | +3.99% | 3,692,728 |
| 24-04-22 | 56.13 | +1.41% | 2,431,658 |
End-of-day quote Shenzhen S.E., April 24, 2024
More quotes
Yunnan Botanee Bio-Technology Group Co LTD is a Chinese company mainly engaged in the production of cosmetics. The Company adopts a sales model based on offline channel sales and online channel sales as the leading factor. The Company's products mainly include creams, skin care lotions, facial masks, essences, lotions and other skin care products and make-up products such as isolation creams, blemish balm (BB) creams, and makeup removers. The Company is also engaged in the research and development, production and sales of skin care-related medical device products, mainly including hyaluronic acid repairing biofilm, hyaluronic acid repairing dressings, mainly used for the protection of skin with damaged barriers after minimally invasive surgery and care.
Sector
Personal Products
Calendar
2024-04-25
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
57.51
CNY
Average target price
90.33
CNY
Spread / Average Target
+57.07%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.64% | 3.36B | |
| +10.09% | 19.15B | |
| 0.00% | 17.54B | |
| -1.32% | 10.84B | |
| -8.05% | 10.22B | |
| +0.76% | 6.53B | |
| +10.78% | 6B | |
| -2.19% | 4.41B | |
| -18.05% | 3.78B | |
| -4.66% | 3.58B |
- Stock Market
- Equities
- 300957 Stock
